European Biomanufacturing SPAC Launched, Backed By Former Sanofi-Aventis CEO Le Fur
With €150m Capital Raise Announced
EureKING hopes to help develop and manufacture novel cell and gene therapies and live biotherapeutics, among other types of biologics, through a number of strategic acquisitions.
